SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950142-17-002071
Filing Date
2017-11-21
Accepted
2017-11-20 18:59:26
Documents
1
Group Members
AISLING CAPITAL III, LPAISLING CAPITAL PARTNERS III LLCAISLING CAPITAL PARTNERS III, LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 eh1701159_13da5-transenterix.htm SC 13D/A 210939
  Complete submission text file 0000950142-17-002071.txt   212846
Mailing Address 635 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 635 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-765-8400
TRANSENTERIX INC. (Subject) CIK: 0000876378 (see all company filings)

IRS No.: 112962080 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42262 | Film No.: 171215073
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10

Mailing Address 888 Seventh Avenue, 30th Fl New York NY 10106
Business Address 888 Seventh Avenue, 30th Fl New York NY 10106 212-651-6380
AISLING CAPITAL III LP (Filed by) CIK: 0001444717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A